Yong Li

机构：Nanchang University, Sichuan University, West China Hospital of Sichuan University, First Affiliated Hospital of Jiangxi Medical College, Hunan Children's Hospital, First Affiliated Hospital of Nanchang University · ORCID：0000-0002-2342-088X

发表论文 17 篇 · 总被引 432 次 · h-index 8

代表论文

• Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors (2020 · Cancer Immunology Immunotherapy · 被引 279)
• Risk of cancer in acromegaly patients: An updated meta-analysis and systematic review (2023 · PLoS ONE · 被引 33)
• Efficacy and tolerability of granulocyte colony-stimulating factors in cancer patients after chemotherapy: A systematic review and Bayesian network meta-analysis (2019 · Scientific Reports · 被引 33)
• External validation of the Khorana score for the prediction of venous thromboembolism in cancer patients: A systematic review and meta-analysis (2024 · International Journal of Nursing Studies · 被引 24)
• Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial (2024 · Gynecologic Oncology · 被引 16)
• LncRNA MIR503HG regulates NETs‐mediated NLRP3 inflammasome activation and NSCLC metastasis by enhancing the ubiquitination of C/EBPβ (2025 · Clinical and Translational Medicine · 被引 12)